A Nature research paper reports reduced effectiveness of vaccine- or infection-elicited antibodies against the SARS-CoV-2 Omicon variant, relative to other viral lineages
and is provided in this format here as a response to the exceptional public-health crisis. This accepted manuscript will continue through the processes of copy editing and formatting to publication of a finalized version of record on nature.com. Please note there may be errors present in this version, which may affect the content, and all legal disclaimers apply.
The Omicron variant of severe acute respiratory syndrome coronavirus 2 was initially identified in November of 2021 in South Africa and Botswana as well as in a sample from a traveler from South Africa in Hong Kong. Since then, B.1.1.529 has been detected globally. This variant seems to be at least equally infectious than B.1.617.2 , has already caused super spreader eventsand has outcompeted Delta within weeks in several countries and metropolitan areas. B.1.1.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cellsMice can make neutralizing antibodies to SARSCoV2 via a complementary pathway not requiring follicular helper T cells or GerminalCenters, says new research from SciImmunology.
Lire la suite »
CDC Advisers Endorse Pfizer COVID Boosters for Teens 12-15CDC advisers are strongly urging that teens as young as 12 get COVID-19 boosters as soon as they're eligible. The CDC’s director, Dr. Rochelle Walensky, will weigh the panel's advice before making a final decision.
Lire la suite »
CDC Endorses COVID Boosters Starting at Age 12If the CDC agrees, about 5 million of the younger teens, those 12 to 15, would be eligible for a booster right away because they got their last shot at least five months ago.
Lire la suite »
High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cellsMice can make neutralizing antibodies to SARSCoV2 via a complementary pathway not requiring follicular helper T cells or GerminalCenters, says new research from SciImmunology.
Lire la suite »
North Texas omicron surge drives up testing demand, increases hospital casesWith the metroplex seeing some of the highest COVID-19 hospitalization numbers since last September, the DFW Hospital Council is urging everyone to take precautions against the omicron variant.
Lire la suite »